| Literature DB >> 21188301 |
Florian Kurth1, Sabine Bélard, Ghyslain Mombo-Ngoma, Katharina Schuster, Ayola A Adegnika, Marielle K Bouyou-Akotet, Peter G Kremsner, Michael Ramharter.
Abstract
BACKGROUND: Sub-Saharan Africa has the highest rates of maternal and neonatal mortality worldwide. Young maternal age at delivery has been proposed as risk factor for adverse pregnancy outcome, yet there is insufficient data from Sub-Saharan Africa. The present study aimed to investigate the influence of maternal adolescence on pregnancy outcomes in the Central African country Gabon. METHODOLOGY AND PRINCIPALEntities:
Mesh:
Year: 2010 PMID: 21188301 PMCID: PMC3004789 DOI: 10.1371/journal.pone.0014367
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Univariable analysis of adolescent compared to adult women.
| Assessments (Number of Women) | Adolescent (≤16 years) | Adult (>16 years) | |
|
| |||
| Birth weight (775) | 2795±514g | 3099±493g | p<0.0001 |
| LBW (775) | 22.8% (13/57) | 9.3% (67/718) | OR 2.9, 95%CI: 1.5–5.6 |
| Gestational age (661) | 38.5±2.6wk | 38.7±2.7wk | p = 0.46 |
| Prematurity (661) | 22.9% (11/48) | 18.8% (115/613) | OR 1.3, 95%CI: 0.6–2.6 |
| Peripheral parasitaemia (775) | 7.0% (4/57) | 1.2% (9/718) | OR 5.9, 95%CI: 1.7–19.9 |
| No. of consultations (356) | 3.3±1.9 | 4.4±1.9 | p<0.01 |
| Consultations < = 3 (356) | 58.3% (14/24) | 33.4% (111/332) | OR 2.8, 95%CI: 1.2–6.5 |
| Use of Bednet (646) | 45.1% (23/51) | 51.4%(306/595) | OR 0.8, 95%CI: 0.4–1.4 |
| Intake of 1 dose IPTp (705) | 86.5% (45/52) | 86.1% (562/653) | OR 1.0, 95%CI: 0.5–2.4 |
| Intake of 2 doses IPTp (691) | 55.8% (29/52) | 60.3% (385/639) | OR 0.8, 95%CI: 0.5–1.5 |
| Haemoglobin at delivery (342) | 6.4±0.9 mmol/l | 6.7±0.9 mmol/l | p = 0.71 |
|
| |||
| Birth weight (275) | 2823±471g | 2971±443g | P<0.01 |
| LBW (275) | 21.4%(12/56) | 12.3%(27/219) | OR 1.9, 95%CI: 0.9–4.1 |
| Gestational Age | 38.6±2.5wk | 38.7±2.8wk | p = 0.83 |
| Preterm Delivery (236) | 21.3% (10/47) | 19.1% (36/189) | OR 1.1, 95%CI: 0.5–2.5 |
| Peripheral parasitaemia (275) | 7.1% (4/56) | 1.8% (4/215) | OR 4.1, 95%CI: 1.1–17.1 |
| No. of consultations (133) | 3.3±1.9 | 4.5±1.9 | p<0.01 |
| Consultations < = 3 (133) | 58.37% (14/24) | 37.6% (41/109) | OR 2.3, 95%CI: 0.9–5.7 |
| Use of Bednet (236) | 44.0% (22/50) | 44.1% (82/104) | OR 1.0, 95%CI: 0.5–1.9 |
| Intake of 1 dose IPTp (257) | 88.3% (45/51) | 84.9% (175/206) | OR 1.3, 95%CI: 0.5–3.3 |
| Intake of 2 doses IPTp (524) | 56.9% (29/51) | 62.6% (127/203) | OR 0.8, 95%CI: 0.4–1.5 |
| Haemoglobin at delivery (124) | 6.7±0.9 mmol/l | 6.8±0.9 mmol/l | p = 0.41 |
LBW = low birth weight, IPTp = intermittent preventive treatment of malaria during pregnancy.
Figure 1Birth weight of term-newborns born to adolescent and adult mothers for each week of gestation.
Bars show mean birth weight and standard deviations for adolescent (≤16 years) and adult (>16 years) mothers.
Multivariable logistic regression analysis for delivery of an infant with low birth weight.
| Category | Variable | N° of deliveries with LBW (%) | Univariable OR (95%CI) | Adjusted OR (95%CI) n = 529 | Adjusted OR (95%CI) (including No. of consultations) n = 298 | ||
|
| Preterm | 38/126 (30.1) | 7.0 (4.1–11.9) |
|
|
|
|
| Term | 31/535 (5.8) | ||||||
|
| ≤16 years | 13/57 (22.8) | 2.9 (1.5–5.6) |
|
| 1.5 (0.3–8.2) | P = 0.65 |
| >16 years | 67/718 (9.3) | ||||||
|
| Nulliparity | 39/275 (14.2) | 1.9 (1.2–3.0) |
|
| 1.0 (0.4–2.5) | P = 0.94 |
| Multiparity | 39/481 (8.1) | ||||||
|
| <2 doses | 36/278 (12.9) | 1.6 (1.0–2.6) | 1.4 (0.8–2.6) | P = 0.25 | 1.4 (0.6–3.7) | p = 0.46 |
| ≥2 doses | 36/415 (8.7) | ||||||
|
| No | 30/317 (9.5) | 0.8 (0.5–1.3) | 0.6 (0.3–1.2) | P = 0.13 | 0.7 (0.3–1.8) | P = 0.49 |
| Yes | 40/331 (12.1) | ||||||
|
| Positive | 1/13 (7.7) | 0.7 (0.1–5.6) | 0.7 (0.1–7.1) | P = 0.7 | 2.01 (0.2–28.5) | P = 0.60 |
| Negative | 79/762 (10.4) | ||||||
|
| ≤3 visits | 22/125 (17.6) | 3.3 (1.6–6.7) |
|
| ||
| >3 visits | 14/231 (6.1) |
LBW = low birth weight, OR = Odds Ratio, IPTp = intermittent preventive treatment of malaria during pregnancy.